A5101883800- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Coronary Interventions and Diagnostics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Hormonal Regulation and Hypertension
- Cardiac electrophysiology and arrhythmias
- Antiplatelet Therapy and Cardiovascular Diseases
Anhui Provincial Hospital
2005-2025
University of Science and Technology of China
2023
Anhui Medical University
2005
The optimal strategy to treat coronary bifurcation lesions (CBL) has been a long-debated topic. combination of stent in the main vessel (MV) and drug-coated balloon (DCB) side branch (SB) seems promising, but evidence is limited. This study aims investigate novel sirolimus-coated treatment non-left CBL compared with paclitaxel-coated balloon. SPACIOUS trial prospective, non-inferiority, multicentre trial. A total 230 patients were randomised sirolimus DCB or paclitaxel group 1:1 ratio....
Background Being female is an independent predictor of adverse events during percutaneous coronary interventions (PCI). Objective To evaluate the safety and efficiency bivalirudin emergency PCI in patients with acute myocardial infarction (AMI). Methods The present study was a subgroup analysis randomized Bivalirudin Acute Myocardial Infarction vs. Heparin GPI plus (BRIGHT) trial. A total 392 enrolled BRIGHT trial were assigned to receive post‐procedure dose infusion ( n = 127) or heparin...
Objective ST-segment elevation myocardial infarction (STEMI) is the most serious type of acute coronary syndrome. This study aimed to investigate efficacy and safety bivalirudin application during primary percutaneous intervention (PPCI) in older patients with STEMI. Methods A total 672 STEMI (>75 years) who underwent PPCI were studied. The endpoints 30-day net adverse clinical events (NACEs) post-emergency intervention, including major cardiac cerebrovascular (MACCEs) Bleeding Academic...
Abstract Background The safety and efficacy of rotational atherectomy (RA) in acute coronary syndrome (ACS) patients treated with different speeds remain unclear. Methods This was an observational retrospective registry. Between February 2017 January 2022, a total 283 ACS were RA. divided into two groups: the low-speed group (130,000-150,000rpm,182 cases) high-speed (160,000-220,000rpm,101 according to maximum RA speed. primary outcome occurrence hypotension, vasospasm, dissection, slow...